Vasileios from Cyprus

Registered at the short selling broker Skilling, 3 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

CARA Therapeutics, Inc. (CARA) shares information

CARA Therapeutics, Inc.

24h Change

-0.50 %


Live rate: Market closed

Stock data per Monday 19 Oct, 2020

-0.07 (-0.50%)
US Market is closed

Live Stock price in graph for CARA Therapeutics, Inc. (CARA)

  • Latest Volume

    326,376 (-2.94 %)

  • Volume prev. day


  • Avg. daily volume


  • Market cap


  • P/E ratio


  • Today high


  • Today low


  • 52 week high


  • 52 week low


  • YTD Change


Quick links

Price target by analysts

The 8 latest analyst estimates, per Tuesday 11 August, 2020, show the following high, low and average price targets.
Target Average: 33.25 USD
Target High: 40 USD
Target Low: 20 USD


Latest news about CARA Therapeutics, Inc.

Below you can find the most recent news posts about CARA Therapeutics, Inc., primarily from US and UK based news sources.

Cannabis Stock Gainers And Losers From October 16, 2020

Saturday, 17 October 2020, 00:25:50
GAINERS: Auxly Cannabis Group (OTCQX: CBWTF ) shares closed up 20.09% at $0.22 Driven Deliveries (OTCQB: DRVD ) shares closed up 12.76% at $0.44 VIVO Cannabis (OTCQX: VVCIF ) shares closed up 11.7% at $0.11 Cansortium (OTCQB: CNTMF ) shares closed up 11.21% at $0.32 Charlottes Web Holdings (OTCQX: CWBHF ) shares closed up 10.34% at $3.20 Cara Therapeutics (NASDAQ: CARA ) shares closed up 7.03% at $14.00 Genetic Technologies (NASDAQ: GENE ) shares closed up 6.93% at … Full story available on
— Benzinga

Choyce Peterson Negotiates 11,685 SF Expansion for Cara Therapeutics Headquarters in Stamford, CT

Monday, 21 September 2020, 14:00:00
NORWALK, Conn. , Sept. 21, 2020 /PRNewswire/ — Choyce Peterson , Inc. ( ), a full-service commercial real estate brokerage and consulting firm, announced that it has successfully concluded negotiations for an 11,685 SF headquarters expansion on behalf of Cara Therapeutics, Inc. (“Cara”) at 107 Elm Street in Stamford, CT . Principal John Hannigan and Vice President Adam Cognetta represented Cara during this transaction. … Full story available on
— Benzinga

Cara Therapeutics Reports Second Quarter 2020 Financial Results

Monday, 10 August 2020, 22:01:00
– Conference call today at 4:30 p.m. ET – STAMFORD, Conn., Aug. 10, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical…
— GlobeNewswire

Cara Therapeutics to Present at the Canaccord Genuity 40th Annual Growth Conference

Thursday, 6 August 2020, 22:01:00
STAMFORD, Conn., Aug. 06, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and…
— GlobeNewswire

Debate on population versus land mass turn into 2022 politics

Monday, 27 July 2020, 23:00:00
The stalemate has stalled the passage of the County Allocation of Revenue (CARA) Bill 2020, which will allow counties to get funds.
— The Standard Digital

Trading broker recommendation

We recommend that you check out as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €/$ 20
Description: offer a large number of stocks for trading. Register an account today and check if they have CARA available or trade one of the many other CFD stocks they have.
Risk warning: 75% of retail investor accounts lose money when trading CFDs with Capital.